Department of Cardiology, Ardahan State Hospital, 75000, Ardahan, Turkey.
Department of Cardiology, Kars Harakani State Hospital, 36200, Kars, Turkey.
Biomark Med. 2024;18(8):363-371. doi: 10.1080/17520363.2024.2347200. Epub 2024 May 24.
There is a lack of data about the association between admission serum albumin levels and long-term mortality in heart failure (HF) patients with cardiac resynchronization therapy defibrillators (CRT-D). We aim to investigate this connection in HF patients with CRT-D. The study population consisted of 477 HF patients with CRT-D. The cohort was divided into three groups according to albumin values, and the relationship between these groups and long-term mortality were evaluated. Long-term all-cause mortality (HR: 3.32, 95% CI: 2.12-6.84), appropriate (HR: 4.44, 95% CI: 2.44-8.06) and inappropriate (HR: 2.95, 95% CI: 1.88-6.02) shocks were higher in the low albumin group. Low albumin levels are associated with the long-term mortality and appropriate shock treatment in HF patients with CRT-D.
血清白蛋白水平与心力衰竭（HF）合并心脏再同步治疗除颤器（CRT-D）患者的长期死亡率之间的关系缺乏数据。我们旨在研究 HF 合并 CRT-D 患者中的这种联系。
研究人群包括 477 例 HF 合并 CRT-D 的患者。根据白蛋白值将队列分为三组，并评估这些组与长期死亡率之间的关系。长期全因死亡率（HR：3.32，95%CI：2.12-6.84）、合适（HR：4.44，95%CI：2.44-8.06）和不合适（HR：2.95，95%CI：1.88-6.02）的电击在低白蛋白组中更高。
低白蛋白水平与 HF 合并 CRT-D 患者的长期死亡率和合适的电击治疗有关。
